PathoVax, a Johns Hopkins University biotech startup commercializing HPV vaccines
PathoVax LLC is a Johns Hopkins University biotech start-up commercializing RGVax, the world’s first comprehensive Human Papillomavirus (HPV) vaccine that targets all clinically relevant HPV strains. In conversation with the […]